Case report: Harel–Yoon syndrome (ATAD3A p.Arg528Trp) with relative cognitive preservation despite severe motor impairment
- 1Department of Neurology, Hospital Militar Central, Universidad Militar Nueva Granada , ,
Abstract
Background: Harel–Yoon syndrome (HAYOS) is a rare neurometabolic disorder caused by pathogenic variants in the ATAD3A gene, a key regulator of mitochondrial dynamics and cellular homeostasis. Although a broad phenotypic spectrum has been described, the relationship between genotype and long-term functional outcomes remains incompletely understood.
Case Presentation: We report two adult sisters with genetically confirmed HAYOS who exhibited early-onset hypotonia progressing to spasticity, craniofacial dysmorphism, optic atrophy, and sensorimotor polyneuropathy. Neuroimaging revealed mild cerebellar atrophy, and electrophysiological studies showed a chronic sensorimotor polyneuropathy with axonal loss and conduction slowing. Initial exome sequencing revealed a variant of uncertain significance in COL5A1, whereas subsequent targeted familial Sanger sequencing confirmed the heterozygous ATAD3A NM_001170535.3:c.1582C>T (p.Arg528Trp) variant in both sisters. Parental segregation could not be assessed because their father died before genetic evaluation and their mother declined further clinical evaluation and targeted segregation testing for the familial ATAD3A variant. Despite severe progressive motor impairment leading to wheelchair dependence, both patients completed formal education and had low-average IQ scores (88 and 82) at single adult assessments.
Conclusion: These cases expand the phenotypic spectrum of HAYOS by demonstrating that severe progressive motor disability may coexist with relative cognitive preservation at adult assessment, limited cardiac or metabolic involvement, and long-term survival. Our findings highlight the diagnostic challenges posed by the ATAD3 locus and underscore the importance of comprehensive genetic evaluation in suspected mitochondrial disorders. Rather than representing a globally mild phenotype, these patients show a motor-severe but cognitively and systemically attenuated presentation, with implications for prognosis, genetic counseling, and clinical management.
Related
- Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice
- Atypical Chemokine Receptor DARC/ACKR1 Is Expressed Selectively by Neurons with Regional Heterogeneity and Protects against Neuroinflammation and Cognitive Impairment
- Dementia Language Models: a generalizable and controllable representation of cognitive impairment
- Distance-dependent Functional Connectivity Strength Analysis Using Resting-State fMRI: Application to Vascular Cognitive Impairment, No Dementia
- Marital status and incident screen-positive cognitive impairment in a Taiwanese longitudinal cohort (2005–2016): Associations vary by cognitive screening instrument
BibTeX
@article{soledad2026case,
title = {{Case report: Harel–Yoon syndrome (ATAD3A p.Arg528Trp) with relative cognitive preservation despite severe motor impairment}},
author = {Paula Nathalia Zamudio Soledad and Juan Sebastián Montoya and David Santiago Poveda-Rodriguez and Luz Mey King Chio Cho and Marco Aurelio Reyes and Oscar Bernal Pacheco},
journal = {Frontiers in genetics},
year = {2026},
month = oct,
doi = {10.3389/fgene.2026.1881863},
url = {https://europepmc.org/article/PMC/PMC13724538},
note = {CC BY},
}
RIS
TY - JOUR
TI - Case report: Harel–Yoon syndrome (ATAD3A p.Arg528Trp) with relative cognitive preservation despite severe motor impairment
AU - Paula Nathalia Zamudio Soledad
AU - Juan Sebastián Montoya
AU - David Santiago Poveda-Rodriguez
AU - Luz Mey King Chio Cho
AU - Marco Aurelio Reyes
AU - Oscar Bernal Pacheco
PY - 2026
DA - 2026/10/19
JO - Frontiers in genetics
DO - 10.3389/fgene.2026.1881863
UR - https://europepmc.org/article/PMC/PMC13724538
AB - Background: Harel–Yoon syndrome (HAYOS) is a rare neurometabolic disorder caused by pathogenic variants in the ATAD3A gene, a key regulator of mitochondrial dynamics and cellular homeostasis. Although a broad phenotypic spectrum has been described, the relationship between genotype and long-term functional outcomes remains incompletely understood. Case Presentation: We report two adult sisters with genetically confirmed HAYOS who exhibited early-onset hypotonia progressing to spasticity, craniofacial dysmorphism, optic atrophy, and sensorimotor polyneuropathy. Neuroimaging revealed mild cerebellar atrophy, and electrophysiological studies showed a chronic sensorimotor polyneuropathy with axonal loss and conduction slowing. Initial exome sequencing revealed a variant of uncertain significance in COL5A1, whereas subsequent targeted familial Sanger sequencing confirmed the heterozygous ATAD3A NM_001170535.3:c.1582C>T (p.Arg528Trp) variant in both sisters. Parental segregation could not be assessed because their father died before genetic evaluation and their mother declined further clinical evaluation and targeted segregation testing for the familial ATAD3A variant. Despite severe progressive motor impairment leading to wheelchair dependence, both patients completed formal education and had low-average IQ scores (88 and 82) at single adult assessments. Conclusion: These cases expand the phenotypic spectrum of HAYOS by demonstrating that severe progressive motor disability may coexist with relative cognitive preservation at adult assessment, limited cardiac or metabolic involvement, and long-term survival. Our findings highlight the diagnostic challenges posed by the ATAD3 locus and underscore the importance of comprehensive genetic evaluation in suspected mitochondrial disorders. Rather than representing a globally mild phenotype, these patients show a motor-severe but cognitively and systemically attenuated presentation, with implications for prognosis, genetic counseling, and clinical management.
SN - 1664-8021
ER -